The role of transcatheter mitral valve leaflet approximation for the treatment of secondary mitral regurgitation: current status and future prospects

Expert Rev Med Devices. 2021 Mar;18(3):261-272. doi: 10.1080/17434440.2021.1899804. Epub 2021 Mar 26.

Abstract

Introduction: Secondary mitral regurgitation (SMR) is one of the most common valvulopathies and is associated with poor prognosis. Over the past years, medical management and mitral valve repair options have rapidly evolved offering new opportunities for a wide range of patients.Areas covered: We provide an up-to-date review of the value of medical and transcatheter mitral valve leaflet approximation for SMR integrating the results of most recent trials and putting their findings into clinical perspective.Expert opinion: Treatment of SMR requires a multidisciplinary approach with a long-term perspective. After optimization of medical treatment, transcatheter mitral valve repair should be considered in patients with persisting symptomatic severe SMR to improve symptoms and prognosis.

Keywords: COAPT; PASCAL; leaflet approximation; Heart failure; MITRA-FR; MitraClip; edge-to-edge repair; secondary mitral regurgitation; transcatheter mitral valve repair; valvular heart disease.

Publication types

  • Review

MeSH terms

  • Cardiac Resynchronization Therapy
  • Heart Valve Prosthesis Implantation / trends*
  • Humans
  • Mitral Valve Insufficiency / diagnosis
  • Mitral Valve Insufficiency / epidemiology
  • Mitral Valve Insufficiency / physiopathology
  • Mitral Valve Insufficiency / surgery*
  • Myocardial Revascularization
  • Prevalence
  • Treatment Outcome